Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2006 2
2009 2
2010 6
2011 3
2012 5
2013 1
2014 1
2015 1
2016 4
2017 4
2018 5
2019 6
2020 1
2021 7
2022 6
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
DDX41 is required for cGAS-STING activation against DNA virus infection.
Singh RS, Vidhyasagar V, Yang S, Arna AB, Yadav M, Aggarwal A, Aguilera AN, Shinriki S, Bhanumathy KK, Pandey K, Xu A, Rapin N, Bosch M, DeCoteau J, Xiang J, Vizeacoumar FJ, Zhou Y, Misra V, Matsui H, Ross SR, Wu Y. Singh RS, et al. Among authors: vizeacoumar fj. Cell Rep. 2022 May 24;39(8):110856. doi: 10.1016/j.celrep.2022.110856. Cell Rep. 2022. PMID: 35613581 Free PMC article.
The CINs of Polo-Like Kinase 1 in Cancer.
Cunningham CE, MacAuley MJ, Vizeacoumar FS, Abuhussein O, Freywald A, Vizeacoumar FJ. Cunningham CE, et al. Among authors: vizeacoumar fj. Cancers (Basel). 2020 Oct 13;12(10):2953. doi: 10.3390/cancers12102953. Cancers (Basel). 2020. PMID: 33066048 Free PMC article. Review.
Targeting the CINful genome: Strategies to overcome tumor heterogeneity.
Cunningham CE, MacAuley MJ, Yadav G, Vizeacoumar FS, Freywald A, Vizeacoumar FJ. Cunningham CE, et al. Among authors: vizeacoumar fj. Prog Biophys Mol Biol. 2019 Oct;147:77-91. doi: 10.1016/j.pbiomolbio.2019.02.006. Epub 2019 Feb 25. Prog Biophys Mol Biol. 2019. PMID: 30817936 Free article. Review.
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia.
K Bhanumathy K, Balagopal A, Vizeacoumar FS, Vizeacoumar FJ, Freywald A, Giambra V. K Bhanumathy K, et al. Among authors: vizeacoumar fj. Cancers (Basel). 2021 Jan 7;13(2):184. doi: 10.3390/cancers13020184. Cancers (Basel). 2021. PMID: 33430292 Free PMC article. Review.
A CRISPR Platform for Targeted In Vivo Screens.
Maranda V, Zhang Y, Vizeacoumar FS, Freywald A, Vizeacoumar FJ. Maranda V, et al. Among authors: vizeacoumar fj. Methods Mol Biol. 2023;2614:397-409. doi: 10.1007/978-1-0716-2914-7_24. Methods Mol Biol. 2023. PMID: 36587138
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.
El Zawily A, Vizeacoumar FS, Dahiya R, Banerjee SL, Bhanumathy KK, Elhasasna H, Hanover G, Sharpe JC, Sanchez MG, Greidanus P, Stacey RG, Moon KM, Alexandrov I, Himanen JP, Nikolov DB, Fonge H, White AP, Foster LJ, Wang B, Toosi BM, Bisson N, Mirzabekov TA, Vizeacoumar FJ, Freywald A. El Zawily A, et al. Among authors: vizeacoumar fj. Clin Cancer Res. 2023 Jul 14;29(14):2686-2701. doi: 10.1158/1078-0432.CCR-22-2535. Clin Cancer Res. 2023. PMID: 36976175 Free PMC article.
59 results